The role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure
- PMID: 20848516
- PMCID: PMC3005084
- DOI: 10.1002/ibd.21314
The role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure
Abstract
Background: Inflammatory bowel diseases (IBDs) require self-management skills that may be influenced by self-efficacy (SE). Self-efficacy represents an individual's perception of his or her ability to organize and execute the behaviors necessary to manage disease. The goal of this study was to develop a valid and reliable measure of IBD-specific SE that can be used in clinical and research contexts.
Methods: One hundred and twenty-two adults with a verified IBD diagnosis participated in the study. Data were pooled from 2 sources: patients from an outpatient university gastroenterology clinic (n=42) and a sample of online respondents (n=80). All participants (N=122) completed the IBD Self-Efficacy Scale (IBD-SES) and the Inflammatory Bowel Disease Questionnaire. Additionally, online participants completed the Brief Symptom Inventory-18 and the Rosenberg Self-Esteem Scale, whereas those in the clinic sample completed the Perceived Health Competence Scale, the Perceived Stress Questionnaire, and the Short Form Version 2 Health Survey.
Results: The IBD-SES was initially constructed to identify 4 distinct theoretical domains of self-efficacy: (1) managing stress and emotions, (2) managing medical care, (3) managing symptoms and disease, and (4) maintaining remission. The 29-item IBD-SES has high internal consistency (r=0.96), high test-retest reliability (r=0.90), and demonstrates strong construct and concurrent validity with established measures.
Conclusions: The IBD-SES is a critical first step toward addressing an important psychological construct that could influence treatment outcomes in IBD.
References
-
- Larsson K, Loof L, Ronnblom A, Nordin K. Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity. Journal of Psychosomatic Research. 2008;64:139–148. - PubMed
-
- van den lejk L, Vlachonikolis IG, Munkholm P, et al. The role of quality of care in health-related quality of life in patients with ibd. Inflammatory Bowel Diseases. 2004;10:392–398. - PubMed
-
- Nordin K, Pahlman L, Larsson K, Sundberg-Hjelm M, Loof L. Health-related quality of life and psychological distress in a population-based sample of swedish patients with inflammatory bowel disease. Scand J Gastroenterology. 2002;2002:450–457. - PubMed
-
- Jones M, Wessinger S, Crowell MD. Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease. Clinical Gastroenterology and Hepatology. 2006;4:474–481. - PubMed
-
- Kane S, Cohen RD, Aikens JE, Hanauer SB. Predictors of non-compliance with mesalamine in quiescent ulcerative colitis. American Journal of Gastroenterology. 2001;96:2929–2932. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources